Diabetes & Coronary Disease
Sort by:
ACC 2024 Insights
ACC 2024 Insights: Use of Guidelines in Treatment of Chronic Coronary Disease in Older Adults
FEATURING
John Mulrow
- 943 views
- April 16, 2024
- 7
HeartFlow
Chest Pain in Women: CT's role in making an accurate diagnosis
FEATURING
Leslee Shaw,
Martha Gulati
- 1,601 views
- April 9, 2024
- 13
International Psoriasis Council (IPC)
How to Identify Cardiovascular Risk in People with Psoriasis
FEATURING
Joel M. Gelfand
- 9 views
- April 2, 2024
International Psoriasis Council (IPC)
Emerging Mechanistic Data Behind Psoriasis and Cardiometabolic Disease
FEATURING
Johann Gudjonsson
- 3 views
- April 2, 2024
University of Louisville
Polygenic Risk Scoring for Coronary Artery Disease
FEATURING
Pradeep Natarajan
- 6 views
- March 29, 2024
International Psoriasis Council (IPC)
Cardiometabolic Comorbidities in Psoriasis: Bridging the Evidence to Practice Gap
FEATURING
Álvaro González-Cantero
- 1 view
- February 28, 2024
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
LDL-C: Earlier and Lower Is Better and Safer?
FEATURING
Paul Rosenblit
- 3,443 views
- November 27, 2023
- 17
National Lipid Association
Targeting Inflammation to Prevent Cardiovascular Disease - Ready for Prime Time?
FEATURING
Michael Garshick
- 1,861 views
- October 11, 2023
- 12
National Lipid Association
Colchicine: Now and What’s Next?
FEATURING
Christie Ballantyne
- 4,884 views
- October 11, 2023
- 24
National Lipid Association
Cardiovascular Disease in Patients with HIV
FEATURING
William R. Short
- 129 views
- October 11, 2023
- 2
The Texas Heart Institute
Cardiometabolic Health: Actionable Prevention Strategies and New Care Models
FEATURING
David Aguilar
- 395 views
- September 7, 2023
- 4
Complex Coronary Cases
A Link Between the Heart and the Brain: New Data on the Elderly
FEATURING
Valentin Fuster
- 579 views
- August 31, 2023
- 6
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
FEATURING
Steven Nissen
- 5,603 views
- July 26, 2023
- 61
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Potential Cardiovascular Benefits in the General Population of Men with ED, in Diabetics, in Men with Other Risk Factors: Are PDE-5 Inhibitors Cardioprotective?
FEATURING
Robert Kloner
- 413 views
- July 11, 2023
- 1
Cedars Sinai
Primary Prevention of Cardiovascular Disease in Women: Blood Pressure, Lipids & Diabetes
FEATURING
Natalie Bello
- 637 views
- July 4, 2023
- 7
Scripps Health
Diabetes and Cardiovascular Disease: Medications and Interventions to Improve Outcomes
FEATURING
Athena Philis-Tsimikas
- 224 views
- June 13, 2023
- 2
Joel M. Gelfand
Improving Cardiovascular Screening in Patients With Psoriasis
- 438 views
- May 25, 2023
- 4
Houston Methodist Hospital
Who is Not Optimally Benefitting From Our Stroke Therapies and What Can We Do About It?
FEATURING
Thomas Kent
- 104 views
- May 11, 2023
ACC 2023 Conference Coverage
ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost
FEATURING
Vicki Groo
- 1,345 views
- April 3, 2023
- 4
ACC 2023 Conference Coverage
ACC 2023: Vascular Factors and Hemodynamics Are Modifiable Risk Factors for Cognitive Impairment
FEATURING
Patrick Moriarty
- 600 views
- March 31, 2023
- 3
Houston Methodist DeBakey Heart and Vascular Center
Impact and Management of Cardiometabolic Disease in Heart Failure
FEATURING
Robert Mentz
- 272 views
- February 10, 2023
- 1
University of Louisville
Update on Coronary Revascularization
FEATURING
Shahab Ghafghazi
- 128 views
- November 17, 2022
- 2